Research Interests

Natural & Botanical Products Drug Discovery & Development, Epigenetics/epigenomics of oxidative stress/inflammation induced diseases including cancer and their prevention/treatment with botanicals/phytochemicals/drugs, Nrf2-mediated anti-oxidative stress/inflammation, Pharmacokinetics (PK)/pharmacodynamics (PD) studies and modeling. Dr. Kong’s current research focuses on, 1) Studies of botanical/dietary/herbal medicinal phytochemicals-mediated epigenetics/epigenomics signaling and diseases prevention such as cancer chemoprevention, 2) Nrf2-mediated redox signaling in anti-oxidative stress, anti-inflammatory, and Phase II drug metabolizing enzymes (DME) /Phase III transporters, 3) Pharmacokinetics (PK)/ pharmacodynamics (PD) studies and PKPD modeling of botanicals/dietary phytochemicals/drugs. Dr. Kong is currently funded by NIH R01CA200129, and R01AT009152.